Navigation Links
Angiotech to Establish Separate Operating and Royalty Businesses
Date:7/7/2008

ed transaction enables Angiotech to

raise a sizable amount of gross proceeds in the form of convertible

securities that will bear non-cash interest payable in kind, and will

be convertible into shares of Angiotech's newly formed subsidiary,

API. The net proceeds that the Company elects to raise will be

utilized to reduce selected principal amounts of the two cash pay

debt securities of Angiotech currently outstanding, significantly

reducing Angiotech's cash interest expense and thereby improving

interest coverage and debt ratios.

- Retain majority API stake for Angiotech shareholders. This

transaction leaves a pro forma API initial ownership stake of between

52% and 68% for Angiotech's existing shareholders (measured

accounting for the convertible notes on an "if converted" basis at

closing). Importantly, Angiotech's existing shareholders will

continue to participate meaningfully in the success of the various

API businesses and product opportunities, including API's proprietary

Quill SRS(TM) technology and its recently approved

5-flourouracil-eluting central venous catheter.

- Mitigates risks related to Angiotech's drug-eluting stent royalty

revenue and cash flows. The debt and cash interest expense reduction

that may be achieved, combined with the significant implied equity

value of Angiotech's ownership stake in API, should improve

Angiotech's ability to continue to meet its debt obligations should

royalties received from its partner Boston Scientific Corporation

("BSC") decline from current levels as a result of additional

competitive entrants into the market for drug-eluting stents.

- Unlock and capture value embedded in Angiotech's non-TAXUS assets.

The conversion ratio of the securities issued impl
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
2. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
3. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
4. Angiotech to participate in UBS Global Life Sciences Conference
5. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
6. Angiotech Receives CE Mark Approval of Quill(TM) SRS MONODERM(TM), a New Rapidly Resorbing Suture Product Line
7. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
8. Angiotech to participate in Bank of America 2007 Credit Conference
9. Angiotech to participate in RBC 2007 Healthcare Conference
10. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
11. Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... , Sept. 16, 2014  Donald Fresne, President and ... of Stephan Vagner , PhD to its Scientific Advisory ... of Toulouse, France , performed research at ... , and at Inserm, the French institute of health and ... works both at the Curie Institute, Orsay, France ...
(Date:9/16/2014)... Oro Valley, Arizona (PRWEB) September 16, 2014 ... company that develops safe and effective products to ... through the use of a proprietary SPACEā„¢ Technology ... Executive Officer and President will present at the ... 18, 2014 at the Hyatt Regency Phoenix. ...
(Date:9/16/2014)... 2014 BCC Research reveals in ... CELLS , the global market for stem cells is ... with a five-year compound annual growth rate (CAGR) of ... Americas with growth projections of $2.2 billion in 2014 ... http://photos.prnewswire.com/prnh/20140805/700528) , Unlike other potential applications of ...
(Date:9/15/2014)... Cancer Immunotherapy Market : Immune ... is a new market research report announced by ... types of therapeutics that have become the major ... (which is often called "immuno-oncology") in recent years: ... immunotherapy. , The regular use of immunotherapy ...
Breaking Biology Technology:New Appointment to the Scientific Advisory Committee at Egenix, Inc. 2Convoy Therapeutics to Present at WhiteHat Investor Conference September 18, 2014 2Convoy Therapeutics to Present at WhiteHat Investor Conference September 18, 2014 3Global Market for Stem Cells to Reach $10.6 Billion in 2018; The Americas Growing at 13.9% CAGR 2Global Market for Stem Cells to Reach $10.6 Billion in 2018; The Americas Growing at 13.9% CAGR 3Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 2Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 3Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 4Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 5
... 15 As drastic cutbacks at major,pharmaceuticals ... drug teams. Social networks have entered the ... are being scrutinized for,ROI. Product recalls and ... on drug marketers. Yet new marketing opportunities ...
... 2006 07/06 ... % % ... 31.99 74.3 27.97 74.7 14 Other EU Countries (2) ... 1.40 3.3 1.27 3.3 10, SLIT ...
... Production of Cloned Animals for Food,is Irresponsible ... Well-being, WASHINGTON, Jan. 15 Farm ... in association with,the American Anti-Vivisection Society (AAVS), ... ending experiments on animals, denounce the Food,and ...
Cached Biology Technology:Beyond DTC: Pharma Industry Faces New Challenges, Competition, Strategies for Market Dominance 2STALLERGENES: 2007: A Further Year of Strong Growth: Up 16% 2Animal Protection Groups Condemn FDA's Endorsement of Animal Cloning 2Animal Protection Groups Condemn FDA's Endorsement of Animal Cloning 3Animal Protection Groups Condemn FDA's Endorsement of Animal Cloning 4
(Date:9/16/2014)... available in Spanish . ... study published in the Journal of Cell Biology ... for proper cell division , At this very moment thousands ... the mechanism by which the body repairs damaged tissues and ... complex process known as "mitosis", during which the cell duplicates ...
(Date:9/16/2014)... BEACH GARDENS, Fla. , Sept. 16, 2014 ... of biometric identity management solutions, announced today the ... solution designed to authenticate the identity of an ... The Android-based Verifier Sentry rapidly reads credential ... credential holder,s ID by matching the biometric to ...
(Date:9/15/2014)... A published study indicates that lowland tapir populations may ... on hunting. Researchers from the Office National de ... Guiana and San Diego Zoo Global reviewed data retrieved ... the last four years and compared this data to ... were placed on hunting tapirs in French Guiana," said ...
Breaking Biology News(10 mins):Unraveling cell division 2Unraveling cell division 3Cross Match Launches New Identity Management Handheld Solution 2
... Water is the life-blood of agriculture; it is the ... of crops needed to feed the world. The ample supply ... between feast and famine. Many parts of the world, however, ... available for agriculture. The reasons can range from drought and ...
... 22, 2010)A joint panel of experts from the Society ... of America (IDSA) today released online new clinical practice ... adults. The guidelines, to be published in the ... , update recommendations regarding the epidemiology, diagnosis, treatment and ...
... they use them, may be far more different then previously ... , according to research funded by the Wellcome Trust. ... Neuroscience , researchers from the University of Glasgow and the ... ,doublesex, (dsx), which determines the shape and structure of the ...
Cached Biology News:More water for life 2More water for life 3New guidelines for diagnosing, managing and treating Clostridium difficile 2Sex on the brain: 'Doublesex' gene key to determining fruit fly gender 2Sex on the brain: 'Doublesex' gene key to determining fruit fly gender 3
...
Bovine Coronary Artery Smooth Muscle Cells (BCASMC) (>500,000 cells)...
... NPY Y2 Receptor antiserum This NPY ... spinal level and is currently being characerized in ... rat and mouse and appears to work better ... in rat. For full characterizarion in dorsal root ...
Bovine Brain Microvascular Endothelial Cells (BBMVEC) (>500,000 cells)...
Biology Products: